Wednesday, July 8, 2026

pharma · Molluscum Contagiosum · Common Warts (Verruca Vulgaris) · VRCA

Verrica Pharmaceuticals

Verrica Pharmaceuticals is a pharma organization headquartered in West Chester, USA. It trades on NYSE under ticker VRCA. Primary therapeutic focus areas include Molluscum Contagiosum, Common Warts (Verruca Vulgaris), Ba

West Chester, USA HQ
2013 Founded
80 Employees
Public company Type
VRCA · NYSE Ticker
Company details
Status
Public
HQ
West Chester, USA
Founded
2013
Employees
80
Programs
7
Drugs
3
Patents
7
Clinical program

VP-102 with applicator

Phase 2 · other · Molluscum Contagiosum

VP-102 with applicator for Molluscum Contagiosum is a Phase 2 program (other) at Verrica Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Internal code VP-102-103

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
Verrica Pharmaceuticals
Phase
Phase 2
Modality
other
Indication
Molluscum Contagiosum
Status
completed
Trials
1

Clinical trials